| Ytd | 62.99% | |
| 1y | 162.27% |
| Open | 15.60 | Prev Close | 15.65 | Low | 15.37 | High | 16.04 | Mkt Cap | 607.96M |
| Vol | 86.72K | Avg Vol | 130.00K | EPS | 0.39 | P/E | 39.38 | Forward P/E | 91.50 |
| Beta | 0.37 | Short Ratio | 0.33 | Inst. Own | 19.22% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 15.06 | 200-d Avg | 12.59 | 1yr Est | 13.72 |
BWAY News
BrainsWay is transitioning from a device manufacturer to a capital-light ecosystem provider for inte
Brainsway Ltd. Sponsored ADR (NASDAQ: BWAY - Get Free Report)'s share price hit a new 52-week high d
Brainsway (BWAY) could be a great choice for investors looking to make a profit from fundamentally s
Terumo, QuidelOrtho, Lumexa Imaging and BrainsWay are tackling industry headwinds through innovation
BrainsWay continues to actively evaluate similar investments in leading North American mental health
BTIG analyst Sam Eiber initiates coverage on BrainsWay (NASDAQ:BWAY) with a Buy rating and announ
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global le
Investment further supports BrainsWay's strategy of partnering with growth-oriented mental health pr
BWAY, HTLD and NCNO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 14th, 202
HTLD, MEOH, NCNO, JD and BWAY have been added to the Zacks Rank #1 (Strong Buy) List on July 14th, 2
Nearly half of individuals diagnosed with PTSD also meet criteria for major depressive disorder (MDD
BURLINGTON, Mass. and JERUSALEM, June 22, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BW
Preliminary Data Analysis Reveals Over 80% Remission Rate One Year after Accelerated Deep TMS Treatm
Investment in provider servicing clinics in Illinois is latest in series of similar transactions by
BrainsWay Ltd. (BWAY) Q1 2026 Earnings Call Transcript
Brainsway NASDAQ: BWAY reported a strong start to 2026, with first-quarter revenue rising 35% year o
R evenue grew approximately 35 % y ear- o ver- y ear to $1 5 .5 million for Q1 2026
Here is how Brainsway Ltd. Sponsored ADR (BWAY) and CG Oncology, Inc. (CGON) have performed compared
Brainsway (BWAY) made it through our "Recent Price Strength" screen and could be a great choice for
BURLINGTON, Mass. and JERUSALEM, April 29, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: B
The Zacks Medical - Products industry faces macro headwinds, keeping growth under pressure in 2026,
BrainsWay continues to deliver strong growth and margin improvement, supported by investments in TMS
During Friday's session, 574 stocks hit new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Monday